Daiwa Securities Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
HA
SL
ACM
CS
WP
Daiwa Securities Group's NBP Position: Q1 2026 in Review
Daiwa Securities Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 346 shares — an estimated $1K sold.
Daiwa Securities Group first reported a position in NBP in Q4 2020 and held it in 13 quarters. The position peaked at $10K in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.
- Daiwa Securities Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 346 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $1K.
- Daiwa Securities Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 13 quarters.
- Daiwa Securities Group's NovaBridge Biosciences American Depositary Shares position peaked at $10K in Q3 2021.
- 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.